Companies similar to Exelixis (EXEL)
Health Care
Exelixis (EXEL)'s closest peers include Merck & Co. (MRK), Bristol Myers Squibb (BMY), Pfizer (PFE), Incyte (INCY) and Lilly (Eli) (LLY). This peer set is drawn from EXEL's enriched company profile and is informational only — not financial advice.
Similar companies
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
PfizerPFEHealth Care
Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular,…
$25.14 (as of 2026-07-16) · market cap $143.1B
-
IncyteINCYHealth Care
A biopharmaceutical company pioneering targeted therapies for blood cancers and inflammatory diseases, with flagship JAK inhibitor JAKAFI generating…
$116.65 (as of 2026-07-16) · market cap $23.2B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,169.17 (as of 2026-07-16) · market cap $1.09T
Not quite? Describe exactly what you want →
Peers are drawn from EXEL's enriched profile (the same similarity signal the chat uses for "companies like EXEL"). See the full profile: Exelixis (EXEL).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.